These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29858240)

  • 1. Monophasic Disease Course in Systemic Lupus Erythematosus.
    Tselios K; Gladman DD; Touma Z; Su J; Anderson N; Urowitz MB
    J Rheumatol; 2018 Aug; 45(8):1131-1135. PubMed ID: 29858240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged clinical remission in patients with systemic lupus erythematosus.
    Steiman AJ; Urowitz MB; Ibañez D; Papneja A; Gladman DD
    J Rheumatol; 2014 Sep; 41(9):1808-16. PubMed ID: 25086082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease course patterns in systemic lupus erythematosus.
    Tselios K; Gladman DD; Touma Z; Su J; Anderson N; Urowitz MB
    Lupus; 2019 Jan; 28(1):114-122. PubMed ID: 30526328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.
    Tselios K; Gladman DD; Touma Z; Su J; Anderson N; Urowitz MB
    Arthritis Care Res (Hoboken); 2019 Jun; 71(6):822-828. PubMed ID: 30055090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged remission in systemic lupus erythematosus.
    Urowitz MB; Feletar M; Bruce IN; Ibañez D; Gladman DD
    J Rheumatol; 2005 Aug; 32(8):1467-72. PubMed ID: 16078321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    Tselios K; Gladman DD; Su J; Urowitz MB
    J Rheumatol; 2016 Mar; 43(3):552-8. PubMed ID: 26773121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients.
    Abdelrahman N; Beresford MW; Leone V;
    Lupus; 2019 Apr; 28(5):667-674. PubMed ID: 30943853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
    Ugarte-Gil MF; Hanly J; Urowitz M; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Pons-Estel BA; Alarcón GS
    Ann Rheum Dis; 2022 Nov; 81(11):1541-1548. PubMed ID: 35944946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
    Fanouriakis A; Adamichou C; Koutsoviti S; Panopoulos S; Staveri C; Klagou A; Tsalapaki C; Pantazi L; Konsta S; Mavragani CP; Dimopoulou D; Ntali S; Katsikas G; Boki KA; Vassilopoulos D; Konstantopoulou P; Liossis SN; Elezoglou A; Tektonidou M; Sidiropoulos P; Erden A; Sfikakis PP; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2018 Dec; 48(3):467-474. PubMed ID: 29555348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR
    Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period.
    Medina-Quiñones CV; Ramos-Merino L; Ruiz-Sada P; Isenberg D
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):981-7. PubMed ID: 26554745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L; Leone V; Pilkington C; Tullus K; Rangaraj S; McDonagh JE; Gardner-Medwin J; Wilkinson N; Riley P; Tizard J; Armon K; Sinha MD; Ioannou Y; Archer N; Bailey K; Davidson J; Baildam EM; Cleary G; McCann LJ; Beresford MW;
    Arthritis Rheum; 2012 Jul; 64(7):2356-65. PubMed ID: 22294381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Quintana R; Gómez-Puerta JA; Catoggio LJ; Alvarellos A; Saurit V; Borba E; Sato E; Costallat L; Da Silva NA; Iglesias-Gamarra A; Neira O; Reyes-Llerena G; Cardiel MH; Amigo MC; Acevedo-Vásquez E; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA
    J Rheumatol; 2019 Oct; 46(10):1299-1308. PubMed ID: 30824636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
    Drucker AM; Su J; Mussani F; Siddha SK; Gladman DD; Urowitz MB
    Lupus; 2016 Apr; 25(4):376-81. PubMed ID: 26453664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.
    das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM
    Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study.
    Fasano S; Coscia MA; Pierro L; Ciccia F
    Lupus; 2021 May; 30(6):991-997. PubMed ID: 33709836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort.
    Petri M; Magder LS
    Arthritis Rheumatol; 2018 Nov; 70(11):1790-1795. PubMed ID: 29806142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study.
    Bello N; Birt JA; Workman J; Zhou X; Ross-Terres JA; Petri M
    Adv Ther; 2022 Jul; 39(7):3131-3145. PubMed ID: 35534786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus exacerbation following cessation of belimumab treatment.
    Furer V; Zisman D; Pokroy-Shapira E; Molad Y; Elkayam O; Paran D
    Scand J Rheumatol; 2016; 45(2):103-6. PubMed ID: 26515057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.